Animal functional magnetic resonance imaging: trends and path toward standardization

F Mandino, DH Cerri, CM Garin, M Straathof… - Frontiers in …, 2020 - frontiersin.org
Animal whole-brain functional magnetic resonance imaging (fMRI) provides a non-invasive
window into brain activity. A collection of associated methods aims to replicate observations …

Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists

JH Krystal, SJ Mathew, DC D'Souza, A Garakani… - CNS drugs, 2010 - Springer
Drugs acting at metabotropic glutamate receptors (mGluRs) are among the most promising
agents under development for the treatment of psychiatric disorders. The research in this …

[HTML][HTML] Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver

SA Schobel, NH Chaudhury, UA Khan, B Paniagua… - Neuron, 2013 - cell.com
The hippocampus in schizophrenia is characterized by both hypermetabolism and reduced
size. It remains unknown whether these abnormalities are mechanistically linked. Here we …

(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions

P Zanos, JN Highland, BW Stewart… - Proceedings of the …, 2019 - National Acad Sciences
Currently approved antidepressant drugs often take months to take full effect, and∼ 30% of
depressed patients remain treatment resistant. In contrast, ketamine, when administered as …

Utility of imaging-based biomarkers for glutamate-targeted drug development in psychotic disorders: a randomized clinical trial

DC Javitt, CS Carter, JH Krystal, JT Kantrowitz… - JAMA …, 2018 - jamanetwork.com
Importance Despite strong theoretical rationale and preclinical evidence, several glutamate-
targeted treatments for schizophrenia have failed in recent pivotal trials, prompting questions …

Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain

BG Jenkins - Neuroimage, 2012 - Elsevier
The technique of functional magnetic resonance (fMRI), using various cognitive, motor and
sensory stimuli has led to a revolution in the ability to map brain function. Drugs can also be …

Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers

S De Simoni, AJ Schwarz, OG O'Daly, AF Marquand… - Neuroimage, 2013 - Elsevier
The pharmacological MRI (phMRI) technique is being increasingly used in both pre-clinical
and clinical models to investigate pharmacological effects on task-free brain function …

The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain

C Montani, C Canella, AJ Schwarz, J Li… - …, 2021 - nature.com
Cholinergic drugs acting at M1/M4 muscarinic receptors hold promise for the treatment of
symptoms associated with brain disorders characterized by cognitive impairment, mood …

Astrocytic regulation of glutamate transmission in schizophrenia

YY Mei, DC Wu, N Zhou - Frontiers in psychiatry, 2018 - frontiersin.org
According to the glutamate hypothesis of schizophrenia, the abnormality of glutamate
transmission induced by hypofunction of NMDA receptors (NMDARs) is causally associated …

Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists

A Gozzi, G Turrini, L Piccoli, M Massagrande… - PloS one, 2011 - journals.plos.org
Orexins are neuro-modulatory peptides involved in the control of diverse physiological
functions through interaction with two receptors, orexin-1 (OX1R) and orexin-2 (OX2R) …